Latest Breaking News On - ஆரோக்கியம் வழிகாட்டுதல்கள் - Page 13 : comparemela.com

Background: Pulmonary arterial hypertension (PAH) is an incurable disease that urgently needs therapeutic approaches. Based on the therapeutic effects of fasudil and dichloroacetate (DCA) on PAH, we aimed to explore the effects and potential mechanism of a new salt, fasudil dichloroacetate (FDCA), in a SU5416 plus hypoxia (SuHx)-induced rat model of PAH. Methods: The rat model of PAH was established by a single subcutaneous injection of SU5416 (20 mg/kg) followed by hypoxia (10% O 2) exposure for 3 weeks. FDCA (15, 45, or 135 mg/kg i.g. daily) or the positive control, bosentan (100 mg/kg i.g. daily), were administered from the first day after SU5416 injection. After 3-week hypoxia, hemodynamic parameters, and histological changes of the pulmonary arterial vessels and right ventricle (RV) were assessed. Additionally, in vitro, the effects of FDCA (50 μM), compared with equimolar doses of fasudil, DCA, or fasudil+DCA, on the proliferation, migration, and contraction of human pulmona

United statesSan diegoUnited kingdomPasmcs sciencellLaboratory animalsChemical technology co ltdImage labAipu instrument equipment co ltdProteintech groupChina pharmaceutical universityCommittee of nanjing medical universityBikai laboratory animal companyCell signaling technologyKey laboratory of natural medicineHuaxi electronic technology co ltdPower lab